Published 12 issues per year
ISSN Print: 1521-9437
ISSN Online: 1940-4344
Indexed in
A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.)Lloyd (Aphyllophoromycetideae) Extract in Patients with Type II Diabetes Mellitus
ABSTRACT
Animal studies have demonstrated that the polysaccharide fractions of Ganoderma lucidum (Ling Zhi, reishi mushroom) have potential hypoglycemic and hypolipidemic activities. This clinical study aimed to evaluate the efficacy and safety of Ganopoly (polysaccharide fractions extracted from G. lucidum by patented technique) in 71 patients with confirmed type II diabetes mellitus (DM). Eligibility criteria included type II DM of >3 months duration for which patients were not receiving insulin; age >18 years; normal vital signs for age and disease state; normal electrocardiogram (ECG); and fasting plasma glucose (FPG) level of 8.9.16.7 mmol/L in sulfonylurea-naive patients or an FPG <10 mmol/L before washout in sulfonylurea-treated patients. Patients were randomly grouped to be given either Ganopoly or placebo orally at 1800 mg three times daily for 12 weeks. Patients underwent 4 weeks of dose adjustment followed by 8 weeks of dose maintenance. Fasting and stimulated glycosylated hemoglobin (HbA1c), plasma glucose, insulin, and C-peptide were monitered at predetermined intervals. Adverse events and hypoglycemic episodes were recorded. The treatment of Ganopoly significantly decreased the mean HbA1c from 8.4 at baseline to 7.6% at 12 weeks. Significant changes in mean FPG and PPG levels at the last visit paralleled the changes in mean HbA1c levels. At baseline, the mean FPG and PPG values in patients treated with Ganopoly were 12.0 and 13.6 mmol/L, respectively. At week 12, mean PPG values had decreased to 11.8 mmol/L. However, these parameters did not change or slightly increased in patients receiving placebo. The between-group difference in PPG levels at week 12 was significant (p < 0.05). Changes in fasting insulin, 2-hour post-prandial insulin, fasting C-peptide, and 2-hour post-prandial C-peptide were consistent, with the between-group differences in these end points being significant at the last visit. Overall, Ganopoly was well tolerated. This study demonstrated that Ganopoly was efficacious and safe in lowering blood glucose concentrations.
-
Gao Yihuai, Gao He, Chan Eli, Tan Wenbo, Lan Jin, Koh Hwee-Ling, Chen Guoliang, Zhou Shufeng, Hypoglycemic Properties of Polysaccharides Extracted from Ganoderma lucidum in Alloxan-Induced Diabetic Rats, Preventive Nutrition and Food Science, 9, 3, 2004. Crossref
-
Klupp Nerida L, Chang Dennis, Hawke Fiona, Kiat Hosen, Grant Suzanne J, Bensoussan Alan, Klupp Nerida L, Ganoderma lucidum for the treatment of cardiovascular risk factors, in Cochrane Database of Systematic Reviews, 2008. Crossref
-
Chu Qing-Ping, Wang Li-En, Cui Xiang-Yu, Fu Hong-Zheng, Lin Zhi-Bin, Lin Shu-Qian, Zhang Yong-He, Extract of Ganoderma lucidum potentiates pentobarbital-induced sleep via a GABAergic mechanism, Pharmacology Biochemistry and Behavior, 86, 4, 2007. Crossref
-
Tang Wenbo, Gao Yihuai, Chen Guoliang, Gao He, Dai Xihu, Ye Jinxian, Chan Eli, Huang Min, Zhou Shufeng, A Randomized, Double-Blind and Placebo-Controlled Study of aGanoderma lucidumPolysaccharide Extract in Neurasthenia, Journal of Medicinal Food, 8, 1, 2005. Crossref
-
Yuen John, Buswell John, Benzie Iris, Ganoderma lucidum (Lingzhi or Reishi), in Herbal Medicine, 20115386, 2011. Crossref
-
Lim Chee Wei, Chan Sheot Harn, Visconti Angelo, Feed-forward neural network assisted by discriminant analysis for the spectroscopic discriminantion of cracked spores Ganoderma lucidum: A prospective biotechnology production tool, AMB Express, 1, 1, 2011. Crossref
-
Meng Guoliang, Zhu Hongyan, Yang Shengju, Wu Feng, Zheng Huihua, Chen E, Xu Jiliang, Attenuating effects of Ganoderma lucidum polysaccharides on myocardial collagen cross-linking relates to advanced glycation end product and antioxidant enzymes in high-fat-diet and streptozotocin-induced diabetic rats, Carbohydrate Polymers, 84, 1, 2011. Crossref
-
Zhou Xuan-Wei, Su Kai-Qi, Zhang Yong-Ming, Applied modern biotechnology for cultivation of Ganoderma and development of their products, Applied Microbiology and Biotechnology, 93, 3, 2012. Crossref
-
De Silva Dilani D., Rapior Sylvie, Hyde Kevin D., Bahkali Ali H., Medicinal mushrooms in prevention and control of diabetes mellitus, Fungal Diversity, 56, 1, 2012. Crossref
-
Lam W.P., Wang C.M., Tsui T.Y., Wai M.S, Tang H.C., Wong Y.W., Lam L.H., Hui L.K., Yew D.T., Extract of white button mushroom affects skin healing and angiogenesis, Microscopy Research and Technique, 75, 10, 2012. Crossref
-
Nahas Richard, Goguen Jeannette, Produits de santé naturels, Canadian Journal of Diabetes, 37, 2013. Crossref
-
Nie Shaoping, Zhang Hui, Li Wenjuan, Xie Mingyong, Current development of polysaccharides from Ganoderma: Isolation, structure and bioactivities, Bioactive Carbohydrates and Dietary Fibre, 1, 1, 2013. Crossref
-
Nahas Richard, Goguen Jeannette, Natural Health Products, Canadian Journal of Diabetes, 37, 2013. Crossref
-
Agustin F., Toharmat T., Evvyernie D., Taniwiryon D., Tarigan S., Blood Profile of Lactating Cows Supplemented with Organic Chromium and Ganoderma lucidum, Pakistan Journal of Nutrition, 11, 10, 2012. Crossref
-
Rahman Mohammad Azizur, Abdullah Noorlidah, Aminudin Norhaniza, Interpretation of mushroom as a common therapeutic agent for Alzheimer’s disease and cardiovascular diseases, Critical Reviews in Biotechnology, 36, 6, 2016. Crossref
-
Siwulski Marek, Sobieralski Krzysztof, Golak-Siwulska Iwona, Sokół Sławomir, Sękara Agnieszka, Ganoderma lucidum (Curt.: Fr.) Karst. – health-promoting properties. A review, Herba Polonica, 61, 3, 2015. Crossref
-
Alzorqi Ibrahim, Manickam Sivakumar, Effects of axial circulation and dispersion geometry on the scale-up of ultrasonic extraction of polysaccharides, AIChE Journal, 61, 5, 2015. Crossref
-
Gill Balraj Singh, Sharma Prateek, Kumar Raj, Kumar Sanjeev, Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling, Tumor Biology, 37, 3, 2016. Crossref
-
Wasser Solomon P., Medicinal Properties and Clinical Effects of Medicinal Mushrooms, in Edible and Medicinal Mushrooms, 2017. Crossref
-
Sum Simon Siu-Man, Ziegler Jane, Lingzhi and Cordyceps, Nutrition in Clinical Practice, 31, 5, 2016. Crossref
-
Alzorqi Ibrahim, Singh Ajit, Manickam Sivakumar, Al-Qrimli Haidar F., Optimization of ultrasound assisted extraction (UAE) of β- d -glucan polysaccharides from Ganoderma lucidum for prospective scale-up, Resource-Efficient Technologies, 3, 1, 2017. Crossref
-
Sum Simon Siu-Man, Ziegler Jane, The Undisclosed Usage of Dietary Supplements in Chinese Elderly Patients, Topics in Clinical Nutrition, 32, 4, 2017. Crossref
-
Amirullah Nur Amalina, Zainal Abidin Nurhayati, Abdullah Noorlidah, The potential applications of mushrooms against some facets of atherosclerosis: A review, Food Research International, 105, 2018. Crossref
-
Hsu Kai-Di, Cheng Kuan-Chen, From nutraceutical to clinical trial: frontiers in Ganoderma development, Applied Microbiology and Biotechnology, 102, 21, 2018. Crossref
-
Seely Dugald, Mills Edward, Rachlis Beth, Patients With Diabetes Using Alternative Medicine, in Evidence-Based Endocrinology, 2006. Crossref
-
Sangeetha B., Krishnamoorthy A.S., Renukadevi P., Malathi V.G., Jeya Sundara Sharmila D., Amirtham D., Antiviral activity of basidiomycetous fungi against Groundnut bud necrosis virus in tomato, Pesticide Biochemistry and Physiology, 166, 2020. Crossref
-
Li Xiu-Ping, Li Jieqing, Liu Honggao, Wang Yuan-Zhong, A new analytical method for discrimination of species in Ganodermataceae mushrooms, International Journal of Food Properties, 23, 1, 2020. Crossref
-
Phu Hoa T., Thuan Duong T.B., Nguyen Thi H.D., Posadino Anna M., Eid Ali H., Pintus Gianfranco, Herbal Medicine for Slowing Aging and Aging-associated Conditions: Efficacy, Mechanisms and Safety, Current Vascular Pharmacology, 18, 4, 2020. Crossref
-
Sharifi-Rad Javad, Butnariu Monica, Ezzat Shahira M., Adetunji Charles Oluwaseun, Imran Muhammad, Sobhani Seyyed Reza, Tufail Tabussam, Hosseinabadi Tahereh, Ramírez-Alarcón Karina, Martorell Miquel, Maroyi Alfred, Martins Natália, Mushrooms-Rich Preparations on Wound Healing: From Nutritional to Medicinal Attributes, Frontiers in Pharmacology, 11, 2020. Crossref
-
Kuypers Kim P. C., Self-Medication with Ganoderma lucidum (“Reishi”) to Combat Parkinson's Disease Symptoms: A Single Case Study, Journal of Medicinal Food, 24, 7, 2021. Crossref
-
Ahmad Md Faruque, Ganoderma lucidum: Persuasive biologically active constituents and their health endorsement, Biomedicine & Pharmacotherapy, 107, 2018. Crossref
-
Aramabašić Jovanović Jelena, Mihailović Mirjana, Uskoković Aleksandra, Grdović Nevena, Dinić Svetlana, Vidaković Melita, The Effects of Major Mushroom Bioactive Compounds on Mechanisms That Control Blood Glucose Level, Journal of Fungi, 7, 1, 2021. Crossref
-
Ahmad Rizwan, Riaz Muhammad, Khan Aslam, Aljamea Ahmed, Algheryafi Mohammad, Sewaket Deya, Alqathama Aljawharah, Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties , Phytotherapy Research, 35, 11, 2021. Crossref
-
El Sheikha Aly Farag El, Nutritional Profile and Health Benefits of Ganoderma lucidum “Lingzhi, Reishi, or Mannentake” as Functional Foods: Current Scenario and Future Perspectives, Foods, 11, 7, 2022. Crossref
-
Zeb Mehreen, Tackaberry Linda E., Massicotte Hugues B., Egger Keith N., Reimer Kerry, Lu Grace, Heiss Christian, Azadi Parastoo, Lee Chow H., Structural elucidation and immuno-stimulatory activity of a novel polysaccharide containing glucuronic acid from the fungus Echinodontium tinctorium, Carbohydrate Polymers, 258, 2021. Crossref
-
Babamiri Shilan, Mojani Qomi Mansooreh Sadat, Shiehmorteza Maryam, The Efficacy of Ganoderma lucidum in Overweight Individuals: A Randomized Placebo-controlled trial, Mediterranean Journal of Nutrition and Metabolism, 15, 2, 2022. Crossref
-
Chan Sze Wa, Tomlinson Brian, Chan Paul, Lam Christopher Wai Kei, The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk, Pharmaceutical Biology, 59, 1, 2021. Crossref